>>>Mundipharma had to buy out the existing distributor, Evomed, to get the distribution rights to ActiPatch<<<
Did they buy EVOMED or just pay them for the rights to sell BIEL products? Either way, it shows the desire of Mundipharma to have these products for their sales force to sell in more countries than what they now sell in.
A very POSITIVE sign, IMO! Maybe they see sales ramping up and demand increasing for these products, with their present clients.